Recent advances and limitations in the application of kahalalides for the control of cancer.
Recent advances and limitations in the application of kahalalides for the control of cancer.
复制标题
DOI:
10.1016/j.biopha.2022.112676
复制
发表时间:
2022-04
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Since the discovery of the kahalalide family of marine depsipeptides in 1993, considerable work has been done to develop these compounds as new and biologically distinct anti-cancer agents. Clinical trials and laboratory research have yielded a wealth of data that indicates tolerance of kahalalides in healthy cells and selective activity against diseased cells. Currently, two molecules have attracted the greates level of attention, kahalalide F (KF) and isokahalalide F (isoKF, Irvalec, PM 02734, elisidepsin). Both compounds were originally isolated from the sarcoglossan mollusk Elysia rufescens but due to distinct structural characteristics it has been hypothesized and recently shown that the ultimate origin of the molecules is microbial. The search for their true source has been a subject of considerable research in the anticipation of finding new analogs and a culturable expression system that can produce sufficient material through fermentation to be industrially relevant.
登录
查看更多内容
影响因子:
4
作者:
Fujiwara, Saori;Ibusuki, Mutsuko;Iwase, Hirotaka
通讯作者:
Iwase, Hirotaka
影响因子:
2.9
作者:
Estella-Hermoso de Mendoza, A.;Calvo, P.;Blanco-Prieto, M. J.
通讯作者:
Blanco-Prieto, M. J.
影响因子:
2.5
作者:
Fagan, Dedra H.;Yee, Douglas
通讯作者:
Yee, Douglas
影响因子:
62.1
作者:
Gao J;Hamann MT
通讯作者:
Hamann MT
DOI:
10.1186/bcr2240
发表时间:
2009
期刊:
Breast cancer research : BCR
影响因子:
--
作者:
Kourtidis A;Srinivasaiah R;Carkner RD;Brosnan MJ;Conklin DS
通讯作者:
Conklin DS